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Introduction
Clinical disorders which exhibit pulmonary pathology, such as cystic fibrosis, 1 are attractive candidates for gene therapy since the lung is an accessible organ. Transgene expression in vivo for therapeutic gain however requires methods that allow efficient gene transfer into target cells or tissue. Gene therapy strategies using nonviral 2, 3 and viral vectors 4, 5 have demonstrated limited efficacy. The immunogenicity of adenoviral vectors [5] [6] [7] and the relative inefficiency of both viral and nonviral gene delivery [8] [9] [10] have been stumbling blocks in finding an effective delivery vehicle for the airways.
To improve the efficiency of nonviral gene delivery, pharmacological agents such as sex hormones and glucocorticoids have been shown to enhance liposomemediated gene uptake 11, 12 and calcium phosphate transfection. 13 Estradiol is a female sex hormone and studies using human breast cancer cells have shown that it can increase liposome-mediated gene uptake in vitro and promote nuclear accumulation of the transgene. 11, 12 These increases are not mediated through the estrogen receptor. 11 Glucocorticoids have a wide range of physiological functions thought to be mediated by intracellular receptor proteins. Clinically, they are used as immunosuppres- sive anti-inflammatory agents. Upon binding of glucocorticoid, the receptor dissociates from a protein complex and enters the nucleus to positively or negatively alter gene regulation by binding to response elements within the DNA sequence. 13 Studies on gene transfer to skeletal muscle cells in vitro and in vivo have shown improvements in reporter gene delivery using a range of glucocorticoids. 14 We have investigated whether these pharmacological agents can enhance nonviral gene delivery to a human airway epithelial cell line for the treatment of pulmonary disease like CF. We have used a human bronchial epithelial cell line (16HBE) as a model for airway gene delivery under several different culture conditions including sub-confluent, confluent and polarized. 15, 16 We have shown significant enhancement of reporter gene delivery in each of these cell culture conditions using ␤-estradiol or methyl-prednisolone. The order in which steroid is combined in the complex is important. Confocal microscopy indicates increased plasmid entry to the cells in the presence of ␤-estradiol. An increase in liposomemediated reporter gene expression in the lungs and nasal epithelia of transfected mice was also observed in vivo. These data indicate that ␤-estradiol and methyl-prednisolone are promising adjuvents for improving gene delivery.
Results

␤-Estradiol enhances liposome-mediated gene expression in human bronchial epithelial cells
Previous studies have shown that ␤-estradiol can enhance gene delivery to human breast cancer cells. 11, 12 We were interested in whether ␤-estradiol could enhance gene delivery to human airway epithelial cells, in particular the 16HBE cell line. We grew these cells to different states of confluency and differentiation before treating them with a luciferase reporter plasmid (pVR1223) complexed with the cationic liposome DCChol/DOPE (lipoplex). The effect of ␤-estradiol on lipoplex-mediated gene delivery was determined by mixing various concentrations of ␤-estradiol with a fixed amount of DCChol/DOPE before the addition of plasmid.
On sub-confluent 16HBE cells, ␤-estradiol enhanced gene delivery to levels significantly higher than lipoplex alone ( Figure 1a) . A 23-fold enhancement over lipoplex was seen using 200 m ␤-estradiol (P Ͻ 0.001). A similar experiment was performed with confluent cells and again significant enhancements were observed when ␤-estradiol was included in the lipoplex at a variety of different concentrations ( Figure 1b) . A 30-fold enhancement over lipoplex was seen when ␤-estradiol was used at 200 m (P Ͻ 0.001). The inclusion of estradiol within the lipoplex at 300 m resulted in a reduction in gene delivery, in both sub-confluent and confluent 16HBE cells, compared with values obtained using 200 m. This was probably due to toxicity arising from use of estradiol at this higher concentration. Repeat experiments on confluent 16HBE cells using 200 m estradiol in the lipoplex gave enhancements over lipoplex of between 45-fold (P Ͻ 0.01 Student's t test, paired, n = 6) and 537-fold (P Ͻ 0.01 Student's t test, paired, n = 6) (data not shown). When the experiment was performed on polarized 16HBE cells grown on Anopore membranes we observed a 900-fold enhancement using ␤-estradiol in the lipoplex compared with lipoplex alone (P Ͻ 0.001) although the actual transfection efficiency was lower than in sub-confluent cells (Table 1) illustrating the increased difficulty of transfecting polarized cells. This reduction in transfection efficiency between sub-confluent and polarized cells was reduced from 360-fold to 9.5-fold by including 200 m ␤-estradiol in the lipoplex. Interestingly, 200 m 17 ␣-estradiol, which does not bind to and activate intracellular estrogen receptors, did not significantly enhance gene expression when included in the lipoplex (Table 1) .
In the previous experiments the optimum concentration of ␤-estradiol required for maximal enhancement was determined against a fixed concentration of DCChol/DOPE. To determine the effect of altering the DCChol/DOPE concentration on ␤-estradiol enhancement we titrated the lipid against a fixed concentration of 150 m ␤-estradiol (Figure 2 ). Using 3 × the DCChol/DOPE concentration gave greater gene delivery than using the standard formulation, although this was not statistically significant. When ␤-estradiol was incorporated into the lipoplex there was a 10-fold increase using 1 × DCChol/DOPE and a 3.8-fold increase using 3 × DCChol/DOPE. The lower enhancement with ␤-estradiol in the 3 × complex probably reflects the overall higher gene delivery seen with the 3 × lipoplex alone. 
Methyl-prednisolone enhances liposome-mediated gene delivery to human bronchial epithelial cells
Previous studies have shown that methyl-prednisolone can enhance gene delivery to human myoblasts. 14 To test whether methyl-prednisolone could also enhance gene delivery in epithelial cells we compared lipoplex with liposteroplex containing methyl-prednisolone using confluent or polarized 16HBE cells. On confluent 16HBE cells, methyl-prednisolone enhanced gene delivery to levels significantly higher than lipoplex alone (Figure 3a) . A 70-fold enhancement over lipoplex was seen when methyl-prednisolone was used at a concentration of 400 m (P Ͻ 0.005 Student's t test) and significant increases were seen at 300 m and 500 m respectively (P Ͻ 0.005 Student's t test, paired). Repeat experiments on confluent 16HBE cells using 400 m methyl-prednisolone in the lipoplex gave enhancements over lipoplex of between 53-fold (P Ͻ 0.01, Student's t test, paired n = 6) and 211-fold (P Ͻ 0.01, Student's t test, paired n = 6) (data not shown). When the experiment was performed on polarized 16HBE cells we observed a 48-fold enhancement with 400 m methyl-prednisolone in the lipoplex (P Ͻ 0.005) compared with lipoplex alone (Figure 3b ).
Treatment of 16HBE cells with ␤-estradiol or methylprednisolone does not increase steroid-mediated enhancement any further
Studies on human breast cancer cells have reported additive effects of including ␤-estradiol in the culture medium after transfection, up to the time of cell harvest. 12 To investigate if this additive effect occurred in human airway cells we transfected confluent 16HBE cells which had been pre-treated with either ␤-estradiol or methylprednisolone and also examined the effect of post-treat-ment with each steroid on pre-treated cells ( Figure 4 ). These results show that highest levels of gene expression are obtained when ␤-estradiol is included only within the lipoplex at the time of gene delivery. In fact, addition of ␤-estradiol after transfection significantly reduced expression compared with both ␤-estradiol pre-treated cells (P Ͻ 0.001 Student's t test, paired) and cells which only had ␤-estradiol in the lipoplex (P Ͻ 0.002 Student's t test, paired). This may be due to a general toxicity to the epithelial cells in prolonged contact with ␤-estradiol.
Methyl-prednisolone pre-treatment significantly reduced gene delivery compared with methyl-prednisolone included in the lipoplex (P Ͻ 0.002 Student's t test, paired). However, post-transfection addition raised gene expression levels of pre-treated cells to similar values obtained without pre-treatment.
Gene transfer efficiency is affected by the order in which ␤-estradiol and methyl-prednisolone-containing complexes are formulated
Other studies using ␤-estradiol to increase gene delivery have involved the addition of steroid after formation of the lipoplex, ie after the plasmid and lipid have been mixed. Our experiments involved mixing the ␤-estradiol or methyl-prednisolone with DCChol/DOPE before the addition of plasmid and in a volume that was 1/10th of the final transfection volume. To determine whether the order of complex formation could influence gene deliv- Gene Therapy ery, we transfected confluent 16HBE cells with ␤-estradiol and methyl-prednisolone-containing lipoplexes which had been formulated in different ways. Steroid was mixed with DCChol/DOPE before addition of plasmid or added to the same final concentration once the lipoplex had been formed ( Figure 5 ). A 9.5-fold lower gene transfer efficiency was observed when ␤-estradiol was added after lipoplex formation (P Ͻ 0.002 Student's t test, paired), although this was still greater than in the absence of ␤-estradiol. Similarly, transfections with methyl-prednisolone showed a 14-fold reduction in gene transfer efficiency when methyl-prednisolone was added after lipoplex formation (P Ͻ 0.0002 Student's t test, paired).
Addition of cholesterol to the transfection complex enhances gene delivery in confluent but not polarized 16HBE cells
Both ␤-estradiol and methyl-prednisolone are derivitives of cholesterol and their basic structure resembles the cholesterol molecule. The similarity in structure may therefore account for their shared effect on gene delivery. Cholesterol could increase gene transfer because its lipophilic nature may enhance cell entry. Indeed, a recent study has shown that free cholesterol can enhance adenoviral vector gene delivery. 17 To determine whether cholesterol could enhance liposome-mediated gene delivery, we included cholesterol in (Student's t test, paired) .
the lipoplex formulation, with the cholesterol being mixed with the DCChol/DOPE before the addition of the luciferase plasmid. We found a two-fold increase in gene expression in confluent 16HBE cells (P Ͻ 0.01 Student's t test, paired n = 6). Pre-treatment and post-treatment of the cells with free cholesterol did not significantly enhance or reduce this enhancement (Figure 6a ). In contrast to ␤-estradiol and methyl-prednisolone, however, Figure 6 The effect upon gene expression of free cholesterol exposure during lipoplex transfection on pre-uptake, uptake and post-uptake stages. Confluent (a) cholesterol did not enhance transfection of polarized cells (Figure 6b ).
␤-Estradiol increases the amount of intracellular plasmid delivered by lipoplex
Plasmid entry into 16HBE cells was visualized using a fluorescently labelled plasmid complexed with DCChol/DOPE with and without ␤-estradiol. A two-fold increase (P Ͻ 0.0001 Student's t test, paired) in the number of cells transfected as well as a seven-fold increase (P Ͻ 0.0001 Student's t test, paired) in the amount of plasmid delivered per cell was seen in the presence of a ␤-estradiol-containing lipoplex compared with lipoplex alone (Table 2 and Figure 7 ). This increase was seen in as short a time as 4 h and the amount of plasmid gradually increased with longer contact times.
␤-Estradiol increases the amount of plasmid within the nucleus of transfected cells
To investigate whether ␤-estradiol could increase the amount of plasmid within the nuclei of cells we transfected confluent 16HBE cells with the luciferase reporter plasmid pVR1223 within a lipoplex or liposteroplex containing either ␣-estradiol or ␤-estradiol and isolated the nuclei from the transfected cells. DNA was isolated from the nuclei and used to transform competent E. coli to quantitate the amount of plasmid within the nuclear fraction. We found a 5.5-fold increase in the number of antibiotic-resistant colonies with liposteroplex containing ␤-estradiol compared with lipoplex alone. Using ␣-estradiol in the liposteroplex resulted in a 2.5-fold decrease in the number of transformants compared with lipoplex alone (Table 3) .
␤-Estradiol can enhance gene delivery to the nasal epithelium and lungs of mice
␤-estradiol-containing lipoplexes were compared with lipoplexes for their ability to deliver the luciferase plasmid to the mouse airway. In lungs, 200 m ␤-estradiol facilitated an approximately seven-fold enhancement compared with lipoplex alone (P = 0.05 Student's t test, paired n = 5). In contrast, using ␤-estradiol at 400 m did not give an enhancement (Figure 8a ). On nasal epithelium a 7.5-fold enhancement was observed when ␤- 11.8 ± 0.8 9.6 ± 0.6 143.2 ± 9.5 ␤-estradiol 16HBE cells were transfected with fluorescently labelled plasmid within a lipoplex or liposteroplex and visualized by con-focal microscopy. Cells containing plasmid were considered as transfected. For both lipoplex and liposteroplex transfections 10 separate fields of view were analysed and the total number of cells and number of cells transfected in each was counted. The amount of plasmid within transfected cells was quantified by counting the number of individual punctate spots of fluorescence in the entire field of view. estradiol was included in the lipoplex compared with lipoplex alone (P Ͻ 0.02 Student's t test, paired n = 6) ( Figure 8b ).
Figure 7 Subcellular distribution of plasmid following ␤-estradiol-enhanced lipoplex mediated gene delivery. Undifferentiated 16HBE cells at approximately 70% confluency were transfected with a rhodamine-labelled plasmid as a lipoplex containing DCChol/DOPE or as a liposteroplex with DCChol/DOPE and 200 m ␤-estradiol. Cells were fixed 4, 8, 12 and 24 h after transfection then visualized by fluorescence confocal microscopy (original magnification × 1000 in all plates) which revealed the subcellular distribution of plasmid (red). A similar liposteroplex with
Discussion
Nonviral methods of gene delivery to human airway epithelia are currently too inefficient to provide therapeutic benefit for pulmonary disorders such as cystic fibrosis. Complexes of cationic lipid and plasmid DNA Gene Therapy (lipoplexes) are the most widely used nonviral delivery system and recent studies have shown that steroids can enhance liposome-mediated gene delivery in human breast tumor cells 11, 12 and in other nonviral systems steroids have increased delivery to human myoblasts and murine muscle. 14 We have investigated the feasibility of using steroids to enhance gene delivery to a human airway epithelial cell line in vitro and to mouse airways in vivo.
Incorporating ␤-estradiol into lipoplexes consistently -based gene delivery and in this respect model the difficulty of gene delivery in vivo. In our studies lipoplex transfection rates are reduced 350-fold moving from sub-confluent to polarized cells. When we incorporate ␤-estradiol into the lipoplex the reduction is only 9.5-fold. Thus, the addition of ␤-estradiol can help to partially overcome the refractory nature of polarized epithelial cells.
Methyl-prednisolone was also incorporated into lipoplexes and assessed on confluent and polarized cells where it increased delivery 70-fold and 48-fold, respectively, compared with lipoplex alone. This represents a considerably larger increase than that previously observed using methyl-prednisolone to enhance calcium phosphate-based delivery to human myoblasts which only gave a 3.3-fold increase. 14 Of crucial importance was the way in which the steroids were presented to the cells. Incubation of cells with steroids before and after transfection has been reported to enhance gene delivery. In our test system this did not enhance delivery further than that obtained with steroid in the lipoplex, and actually decreased delivery in the case of ␤-estradiol, which may have been due to a toxicity effect. Importantly, we found that the order in which the steroid-containing complex (liposteroplex) was formed was of greater importance. If the steroid was mixed with DCChol/DOPE before the addition of plasmid a greater enhancement was achieved than if the steroid was added after the plasmid. This suggests that the steroid is an integral part in the complex and it may be excluded from pre-formed complexes between plasmid and DCChol/DOPE.
The enhancement in gene delivery was also observed with other steroids but was not universal. 250 m testosterone enhanced gene expression 21-fold in confluent 16HBE cells (P Ͻ 0.05 Student's t test, paired n = 3) (data not shown) while 300 m progesterone enhanced gene expression in sub-confluent 16HBE cells 23-fold over lipoplex alone (P Ͻ 0.05 Student's t test, paired n = 3) (data not shown). Other steroids were also tested for enhancement of gene delivery. In contrast, corticosterone, cortisone and dexamethasone all failed to enhance delivery to sub-confluent 16HBE cells above that achieved with lipoplex alone.
The importance of the DCChol/DOPE concentration in a steroid containing lipoplex was shown by increasing the amount used three-fold; there was only a slight increase in lipoplex delivery but when estradiol was included in the complex a significant increase was seen. ␤-Estradiol and methyl-prednisolone share a similar cholesterol-based structure and free cholesterol gave a significant enhancement in gene expression in confluent 16HBE cells but unlike ␤-estradiol or methyl-predniso-lone there was no enhancement using polarized cells. This cholesterol enhancement on confluent cells may explain why increasing the DCChol/DOPE concentration within the lipoplex caused an increase in gene delivery.
The effect of ␤-estradiol on lipoplex-mediated gene delivery was evaluated in vivo to murine lung and nasal tissue. ␤-Estradiol enhanced expression in both tissue types but not as effectively as in vitro. This may simply reflect the need to optimize the transfection conditions in vivo or may indicate additional barriers to gene delivery that are not present in vitro. In addition, further in vivo analysis will be needed to determine the cell types that are transfected by steroid-containing lipoplexes.
Confocal microscopy showed an increase in plasmid entry into cells when ␤-estradiol was incorporated into the lipoplex and also an increase in the number of cells transfected. Plasmid was rarely observed in the nucleus of over 200 cells analyzed indicating that nuclear entry may be a major rate-limiting step once a plasmid is inside the cell.
␤-Estradiol has been reported to alter cellular membrane fluidity in human breast cancer cells 20 which may account for the increase in plasmid entering 16HBE cells in the presence of ␤-estradiol compared with DC/Chol DOPE. The mechanism by which ␤-estradiol and methylprednislone enhance liposome-mediated gene delivery is not known. The lipophilic nature of steroid hormones means that they can enter cells by diffusion through the plasma membrane although some steroid hormones including estrogen are also internalized by receptormediated endocytosis. 21, 22 This could account for the large reduction in the transfection efficiency when the cells are pre-treated with methyl-prednisolone if there was binding and down-regulation of these sites. Interestingly, 17 ␣-estradiol, which does not bind to intracellular estrogen receptors, had no significant effect on luciferase reporter gene expression to confluent 16HBE cells when incorporated into a lipoplex at 200 m. However, when plasmid was visualized by con-focal microscopy ␣-estradiol in the lipoplex was found to increase plasmid entry into cells, much like ␤-estradiol. Significantly, when the amount of plasmid in the nucleus was quantitated by transfection of E. coli to antibiotic resistance ␤-estradiol increased the amount of nuclear plasmid while ␣-estradiol actually decreased this relative to lipoplex alone. This may indicate that there are two components to the ability of estradiol to enhance gene delivery: one which promotes increased entry of plasmid across the cell membrane, common to both ␣ and ␤ estradiols, and a second which relies on binding to intracellular estrogen receptors and subsequent trafficking to the nucleus of the cell, an activity specific to ␤-estradiol.
These studies have shown that ␤-estradiol and methylprednisolone as well as some other steroids have the ability to enhance reporter gene delivery to polarized 16HBE cells in vitro. In vivo enhancement in both murine lung and nasal tissue with ␤-estradiol, was also seen and is encouraging. Hopefully, further optimization can increase the levels of in vivo gene delivery. These studies indicate that steroids can influence delivery in airway epithelial cells both in vitro on polarized cells and in vivo and therefore may have the potential to improve gene therapy.
Gene Therapy
Materials and methods
Reagents
Unless stated otherwise reagents were obtained from Sigma-Aldrich Ltd (Poole, UK).
Cell culture
Human bronchial epithelial cells 16HBE 16 (generously provided by Professor Dieter Gruenert, University of Vermont, VT, USA) were grown in minimal essential medium with Earle's salts (Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum (FCS; TCS Biologicals, Buckingham UK), 2 mm l-glutamine (Life Technologies) 100 units/ml penicillin and streptomycin (Life Technologies). Culture of polarized cells on Anopore membranes (Life Technologies) differed in that the FCS was replaced by 2% Ultroser G (Life Technologies). For transfection studies upon sub-confluent 16HBE cells, the cells were seeded to reach 70% confluency at the time of transfection. For transfection of confluent cells, the cells were used 2 to 3 days after reaching 100% confluency. For studies using polarized cells, the cells were grown in 10 mm diameter tissue culture chambers containing 0.2 m Anopore membranes and cultured for at least 10 days after confluency. Cell polarization was confirmed by measuring the transepithelial electrical resistance of the epithelial cell layer with an EVOM voltmeter (World Precision Instruments, FL, USA).
In vitro gene transfer
Cells were seeded in six-well multidishes (Life Technologies) for confluent and sub-confluent transfection. Before transfection, cells were rinsed sequentially with PBS and Optimem (Life Technologies). Usually 1 g of the luciferase reporter plasmid pVR1223 23 (generously provided by Vical, San Diego, CA, USA) and 5 g of DCChol/DOPE (generously provided by Professor L Huang, University of Pittsburgh, PA, USA) each diluted in 100 l of Optimem, were mixed and incubated at room temperature for 15 min and then added to each well for 4 h at 37°C, 5% CO 2 , after which the transfection complex was removed and the cells were rinsed with PBS. Fresh growth medium was added and the cells were grown for a further 48 h before being assayed for luciferase activity.
Transfection procedure involving estradiols and methyl prednisolone Estradiols (␤-estradiol (17␤-estradiol; 1,3,5(10)-estratriene3, 17␤-diol) and ␣-estradiol (17␣-estradiol; 1,3,5(10)-estratriene3, 17␣-diol) (Sigma, Poole, UK) were dissolved in 95% ethanol. 6␣-Methyl-prednisolone 21-hemisuccinate was dissolved in water. In certain experiments ␤-estradiol and methyl-prednisolone were used either during the uptake phase, before and during the uptake phase or before, during and after uptake phases. In other experiments ␣-estradiol, ␤-estradiol and methyl-prednisolone were combined directly with DC-Chol/DOPE before the addition and mixing with plasmid or added at the required concentration to the final volume of medium.
Luciferase reporter assay
Cells transfected with pVR1223 were washed twice with PBS and lysed using 300 l per well of reporter lysis buffer (RLB) (Promega, Madison, WI, USA). Cell lysates were treated as described by Promega using their Luciferase assay system. Relative light units (RLU) were measured using a Turner TD 20/20 Luminometer, after a 3 s delay, over a 10 s integration period. Luciferase activity was standardized to the protein content of each sample determined using the BioRad protein assay (BioRad, Hemel Hempstead, UK). Protein concentrations were calculated from a BSA standard curve and luciferase activity was expressed in RLU/g protein or RLU/mg protein.
Subcellular localization of plasmid
When investigating the subcellular localization of plasmid, sub-confluent 16HBE cells were transfected with 0.2 g of a rhodamine-labelled fluorescent plasmid (Gene Therapy Systems, San Diego, CA, USA) and 1 g DCChol/DOPE each diluted in 25 l of Optimem. Both were mixed and then incubated at room temperature for 15 min then added to cells for up to 4 h at 37°C, 5% CO 2 . At varying time-points after transfection, cells were sequentially washed with PBS and Cell Scrub Buffer (Gene Therapy Systems) before fixing in 4% paraformaldehyde in PBS. Fixed cells were washed twice for 5 min with PBS before being mounted using Vectashield medium (Vector Laboratories, Peterborough, UK) Cells were visualized using a Leica TCS inverted confocal microscope. A mixed gas laser was used to generate a 568 nm band for imaging the rhodamine-labelled plasmid.
Purification of the 16HBE nuclear fraction and E. coli transformation Subcellular fractionation was performed as previously described. 24 Following lysis of nuclei, DNA was precipitated by adding ethanol and centrifuged (13 000 g, 15 min). After washing with 70% ethanol the pellet was resuspended in 10 mm Tris HCl, pH 8.5. A 10 l aliquot was then used to transform TOP 10 competent E. coli cells (Invitrogen, Groningen, The Netherlands). Transformants were selected on the basis of kanamycin resistance conferred by the luciferase reporter plasmid pVR1223.
Intranasal delivery of lipoplex to Balb/c mice
Female mice (6-8 weeks old) were anaesthetized using the inhalational anaesthetic methoxyflurane (Metofane; Mallinckrodt Veterinary, Mundelein, IL, USA). For intranasal delivery, mice were held such that pressure was applied to the lower mandible to immobilize the tongue and thus prevent swallowing. Lipoplexes containing either 10 g or 20 g pVR1223 were complexed with 50 g or 100 g of DCChol/DOPE, respectively. Where ␤-estradiol was used it was added to the DCChol/DOPE at 200 m (relating to final lipoplex volume) before the addition of pVR1223. Lipoplex, in a total volume of 200 l, was added to the nasal planum, the respiratory pattern of the mice resulted in prompt inhalation of the transfection complex. Mice were monitored during recovery to consciousness.
Processing of lung and nasal tissue
Mice were killed 2 days after transfection. Nasal epithelium was dissected from each animal and homogenized manually in a 1.5 ml microfuge tube with 150 l RLB, and placed on dry ice. Lungs were dissected from each animal and transferred to 200 l RLB, mechanically homogenized (Pro 200 homogenizer; Pro Scientific, Monroe, CT, USA) and then placed on dry ice. Frozen samples were thawed and cell debris pelleted by a 12 000 g spin for 2 min. Luciferase reporter assays were performed on all samples.
Statistical analysis of data
Graphs were presented and quantitative results were compared by a paired Student's t test using SigmaPlot (Statistical Solutions Ltd, Cork, Ireland).
